Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice

Risa Nasu, Hirotami Matsuo, Hitomi Takanaga, Hisakazu Ohtani, Yasufumi Sawada

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Parkinsonism can be a side effect of antipsychotic drugs, and has recently been reported with peripherally acting drugs such as calcium channel blockers, antiarrhythmic agents and so on. In this study, we examined the quantitative prediction of drug-induced catalepsy by amoxapine, cinnarizine and cyclophosphamide, which have been reported to induce parkinsonism. Dose-dependent catalepsy was induced by these drugs in mice. In vivo dopamine D1, D2 and muscarinic acetylcholine (mACh) receptor occupancies by these drugs in the striatum were also examined. The in vitro binding affinities (Ki values) of amoxapine and cinnarizine to dopamine D1, D2 and mACh receptors in rat striatal synaptic membrane were 200 and 2900 nM, 58.4 and 76.4 nM and 379 and 290 nM, respectively. Cyclophosphamide did not bind to these receptors at concentrations up to 100 μM. Twenty drugs, including those mentioned above, showed a significant correlation between the observed intensity of catalepsy and the values predicted with a pharmacodynamic model (Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab Disp 1997; 25: 675-684) based on in vivo occupancy of dopamine D1, D2 and mACh receptors. We conclude that occupancy of dopamine D1 and D2 receptors contributes to catalepsy induction by amoxapine and cinnarizine.

Original languageEnglish
Pages (from-to)129-138
Number of pages10
JournalBiopharmaceutics and Drug Disposition
Volume21
Issue number4
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Amoxapine
Cinnarizine
Catalepsy
Cyclophosphamide
Muscarinic Receptors
Dopamine
Pharmaceutical Preparations
Parkinsonian Disorders
Corpus Striatum
Dopamine D1 Receptors
Synaptic Membranes
Dopamine D2 Receptors
Calcium Channel Blockers
Drug-Related Side Effects and Adverse Reactions
Antipsychotic Agents

Keywords

  • Amoxapine
  • Catalepsy
  • Cinnarizine
  • Cyclophosphamide
  • Parkinsonism
  • Receptor occupancy

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice. / Nasu, Risa; Matsuo, Hirotami; Takanaga, Hitomi; Ohtani, Hisakazu; Sawada, Yasufumi.

In: Biopharmaceutics and Drug Disposition, Vol. 21, No. 4, 2000, p. 129-138.

Research output: Contribution to journalArticle

Nasu, Risa ; Matsuo, Hirotami ; Takanaga, Hitomi ; Ohtani, Hisakazu ; Sawada, Yasufumi. / Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice. In: Biopharmaceutics and Drug Disposition. 2000 ; Vol. 21, No. 4. pp. 129-138.
@article{2028fb8f26274d51ab9a1ea5a7698cf9,
title = "Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice",
abstract = "Parkinsonism can be a side effect of antipsychotic drugs, and has recently been reported with peripherally acting drugs such as calcium channel blockers, antiarrhythmic agents and so on. In this study, we examined the quantitative prediction of drug-induced catalepsy by amoxapine, cinnarizine and cyclophosphamide, which have been reported to induce parkinsonism. Dose-dependent catalepsy was induced by these drugs in mice. In vivo dopamine D1, D2 and muscarinic acetylcholine (mACh) receptor occupancies by these drugs in the striatum were also examined. The in vitro binding affinities (Ki values) of amoxapine and cinnarizine to dopamine D1, D2 and mACh receptors in rat striatal synaptic membrane were 200 and 2900 nM, 58.4 and 76.4 nM and 379 and 290 nM, respectively. Cyclophosphamide did not bind to these receptors at concentrations up to 100 μM. Twenty drugs, including those mentioned above, showed a significant correlation between the observed intensity of catalepsy and the values predicted with a pharmacodynamic model (Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab Disp 1997; 25: 675-684) based on in vivo occupancy of dopamine D1, D2 and mACh receptors. We conclude that occupancy of dopamine D1 and D2 receptors contributes to catalepsy induction by amoxapine and cinnarizine.",
keywords = "Amoxapine, Catalepsy, Cinnarizine, Cyclophosphamide, Parkinsonism, Receptor occupancy",
author = "Risa Nasu and Hirotami Matsuo and Hitomi Takanaga and Hisakazu Ohtani and Yasufumi Sawada",
year = "2000",
doi = "10.1002/1099-081X(200005)21:4<129::AID-BDD224>3.0.CO;2-F",
language = "English",
volume = "21",
pages = "129--138",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Quantitative prediction of catalepsy induced by amoxapine, cinnarizine and cyclophosphamide in mice

AU - Nasu, Risa

AU - Matsuo, Hirotami

AU - Takanaga, Hitomi

AU - Ohtani, Hisakazu

AU - Sawada, Yasufumi

PY - 2000

Y1 - 2000

N2 - Parkinsonism can be a side effect of antipsychotic drugs, and has recently been reported with peripherally acting drugs such as calcium channel blockers, antiarrhythmic agents and so on. In this study, we examined the quantitative prediction of drug-induced catalepsy by amoxapine, cinnarizine and cyclophosphamide, which have been reported to induce parkinsonism. Dose-dependent catalepsy was induced by these drugs in mice. In vivo dopamine D1, D2 and muscarinic acetylcholine (mACh) receptor occupancies by these drugs in the striatum were also examined. The in vitro binding affinities (Ki values) of amoxapine and cinnarizine to dopamine D1, D2 and mACh receptors in rat striatal synaptic membrane were 200 and 2900 nM, 58.4 and 76.4 nM and 379 and 290 nM, respectively. Cyclophosphamide did not bind to these receptors at concentrations up to 100 μM. Twenty drugs, including those mentioned above, showed a significant correlation between the observed intensity of catalepsy and the values predicted with a pharmacodynamic model (Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab Disp 1997; 25: 675-684) based on in vivo occupancy of dopamine D1, D2 and mACh receptors. We conclude that occupancy of dopamine D1 and D2 receptors contributes to catalepsy induction by amoxapine and cinnarizine.

AB - Parkinsonism can be a side effect of antipsychotic drugs, and has recently been reported with peripherally acting drugs such as calcium channel blockers, antiarrhythmic agents and so on. In this study, we examined the quantitative prediction of drug-induced catalepsy by amoxapine, cinnarizine and cyclophosphamide, which have been reported to induce parkinsonism. Dose-dependent catalepsy was induced by these drugs in mice. In vivo dopamine D1, D2 and muscarinic acetylcholine (mACh) receptor occupancies by these drugs in the striatum were also examined. The in vitro binding affinities (Ki values) of amoxapine and cinnarizine to dopamine D1, D2 and mACh receptors in rat striatal synaptic membrane were 200 and 2900 nM, 58.4 and 76.4 nM and 379 and 290 nM, respectively. Cyclophosphamide did not bind to these receptors at concentrations up to 100 μM. Twenty drugs, including those mentioned above, showed a significant correlation between the observed intensity of catalepsy and the values predicted with a pharmacodynamic model (Haraguchi K, Ito K, Kotaki H, Sawada Y, Iga T. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies. Drug Metab Disp 1997; 25: 675-684) based on in vivo occupancy of dopamine D1, D2 and mACh receptors. We conclude that occupancy of dopamine D1 and D2 receptors contributes to catalepsy induction by amoxapine and cinnarizine.

KW - Amoxapine

KW - Catalepsy

KW - Cinnarizine

KW - Cyclophosphamide

KW - Parkinsonism

KW - Receptor occupancy

UR - http://www.scopus.com/inward/record.url?scp=0034511936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034511936&partnerID=8YFLogxK

U2 - 10.1002/1099-081X(200005)21:4<129::AID-BDD224>3.0.CO;2-F

DO - 10.1002/1099-081X(200005)21:4<129::AID-BDD224>3.0.CO;2-F

M3 - Article

C2 - 11180191

AN - SCOPUS:0034511936

VL - 21

SP - 129

EP - 138

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 4

ER -